AR043071A1 - Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica - Google Patents

Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica

Info

Publication number
AR043071A1
AR043071A1 ARP980105434A ARP980105434A AR043071A1 AR 043071 A1 AR043071 A1 AR 043071A1 AR P980105434 A ARP980105434 A AR P980105434A AR P980105434 A ARP980105434 A AR P980105434A AR 043071 A1 AR043071 A1 AR 043071A1
Authority
AR
Argentina
Prior art keywords
macrolides
treatment
pharmaceutical composition
macular degeneration
cancer
Prior art date
Application number
ARP980105434A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR043071A1 publication Critical patent/AR043071A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Uso de macrólidos para la fabricación de un medicamento para el tratamiento de tumores y la degeneración macular en un humano o paciente veterinario que comprende un compuesto seleccionado entre un resto de grupo de fórmula (1), y una composición farmacéutica que comprende un vehículo farmacéuticamente aceptable y un compuesto de la misma.
ARP980105434A 1997-10-31 1998-10-29 Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica AR043071A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31

Publications (1)

Publication Number Publication Date
AR043071A1 true AR043071A1 (es) 2005-07-20

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105434A AR043071A1 (es) 1997-10-31 1998-10-29 Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica

Country Status (17)

Country Link
EP (1) EP1027060A2 (es)
JP (1) JP2001521891A (es)
KR (1) KR20010031577A (es)
CN (1) CN1278178A (es)
AR (1) AR043071A1 (es)
AU (1) AU1206799A (es)
BG (1) BG104436A (es)
BR (1) BR9813318A (es)
CA (1) CA2307850A1 (es)
HU (1) HUP0100012A3 (es)
IL (1) IL135518A0 (es)
NO (1) NO20002189L (es)
PL (1) PL340604A1 (es)
SK (1) SK6172000A3 (es)
TR (1) TR200001147T2 (es)
WO (1) WO1999022722A2 (es)
ZA (1) ZA989885B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1278881B1 (en) 2000-04-13 2009-12-30 Biotica Technology Limited Hybrid glycosylated products and their production and use
CA2498191C (en) 2002-09-18 2012-04-10 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
WO2004087673A2 (en) 2003-03-28 2004-10-14 Sloan-Kettering Institute For Cancer Research Migrastatin analogs and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
JP5149001B2 (ja) 2004-05-25 2013-02-20 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ 癌の処置におけるマイグラスタチンアナログ
WO2006034478A2 (en) 2004-09-23 2006-03-30 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
US8637070B2 (en) 2005-02-09 2014-01-28 Santen Pharmaceutical Co., Ltd. Rapamycin formulations and methods of their use
WO2007011880A2 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
DK1934238T3 (en) 2005-08-24 2017-09-18 Melinta Therapeutics Inc TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE
EP1934237A2 (en) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
CN106317146B (zh) * 2015-06-18 2019-06-21 沈阳药科大学 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
KR20010031577A (ko) 2001-04-16
HUP0100012A2 (hu) 2001-05-28
CA2307850A1 (en) 1999-05-14
NO20002189L (no) 2000-06-28
WO1999022722A3 (en) 1999-08-05
IL135518A0 (en) 2001-05-20
BR9813318A (pt) 2000-08-22
EP1027060A2 (en) 2000-08-16
SK6172000A3 (en) 2001-03-12
AU1206799A (en) 1999-05-24
JP2001521891A (ja) 2001-11-13
HUP0100012A3 (en) 2003-07-28
WO1999022722A2 (en) 1999-05-14
TR200001147T2 (tr) 2000-08-21
BG104436A (en) 2000-12-29
NO20002189D0 (no) 2000-04-27
PL340604A1 (en) 2001-02-12
CN1278178A (zh) 2000-12-27
ZA989885B (en) 1999-05-05

Similar Documents

Publication Publication Date Title
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
GEP20043324B (en) Purine Derivatives
PT1292594E (pt) Derivados de quinazolina para o tratamento de tumores
SE9904505D0 (sv) Novel compounds
ES2159591T3 (es) Composicion de liberacion controlada.
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
CY1109364T1 (el) Ενας συνδυασμος που περιλαμβανει κομβρεταστατινη και αντικαρκινικους παραγοντες
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
UA50719C2 (uk) Проліки для терапії пухлин і запальних захворювань
AR023806A1 (es) Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas
AR011133A1 (es) MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA.
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
AR017440A1 (es) Uso de un inhibidor de fpt y de un agente antineoplasico en la preparacion de un medicamento para terapia de combinacion
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
IL165086A (en) Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
AR014640A1 (es) UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler

Legal Events

Date Code Title Description
FB Suspension of granting procedure